License Agreements (Tables)

12 Months Ended

Dec. 31, 2019

License Agreement [Abstract]

Schedule of research and development expenses for licenses acquired

	For the Years Ended December 31,
	2019		2018
Chelexa BioSciences, Inc.	$	-	$	132,164
The George Washington University		2,500		-
University of Maryland and Isoprene Pharmaceuticals, Inc.		10,000		-
North Carolina State University		25,000		-
University of Cincinnati		7,500		7,500
Zylö Therapeutics Inc.		50,000		-
Other		-		91,028
	$	95,000	$	230,692